BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, June 13, 2026
Home » Topics » Medical technology

Medical technology
Medical technology RSS Feed RSS

MDD's Diagnostic Extra

Oct. 4, 2013

Newco on the Go: Vital Connect's HealthPatch next step in wearable biosensor tech

Oct. 4, 2013
By Omar Ford
Unsustainable trends including aging demographics, chronic disease, cost of care, and caregiver shortage are driving a global healthcare crisis and even threatening the global economy. Wearable biosensor technology that remotely connects patients and caregivers is the force-multiplier to address these global challenges. The global market for biosensors to monitor health for aging, clinical, and consumer health will exceed $100 billion annually by 2015.
Read More

New sinusitis implant promising in pilot study

Oct. 4, 2013
By Amanda Pedersen

International report: St. Jude implants Quadripolar Pacemaker in Hong Kong

Oct. 4, 2013

Washington roundup: Early feasibility guidance surfaces; allows OUS data

Oct. 4, 2013
By Mark McCarty

Agreements/contracts: Noble Biomaterials continues relationship with KCI solutions

Oct. 4, 2013

Financings roundup: Health Care REIT prices $400M of 4.5% senior unsecured notes

Oct. 4, 2013

After the CR fistfight: fiscal crisis remains

Oct. 3, 2013
By Mark McCarty
As the debate over the continuing resolution persists, medical device makers are not the only ones wondering when and how it will end. The device tax repeal has been floated as a condition of a continuing resolution, but it might also be instructive to ask ourselves what the future holds for med tech. Part of the reason for the partisan nature of the CR debate is that the Affordable Care Act – the legislation that gave rise to the device tax – was itself the most partisan piece...
Read More

Looking for an edge in China: Boston Scientific opens new innovation center in Shanghai

Oct. 3, 2013
By Kristine Yang
With China becoming increasingly competitive for device makers, Boston Scientific (Natick, Massachusetts) has set up a new research center to seek out innovations and better tailor products to the market.
Read More

The MDD Interview: Darnaud: 'People were frightened,panicking. I had to take charge.'

Oct. 3, 2013
By John Brosky
Previous 1 2 … 3424 3425 3426 3427 3428 3429 3430 3431 3432 … 10250 10251 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 12, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 9, 2026
  • Blood sample tubes after centrifuge

    Pre-disease plasma signature may help redefine lung cancer risk

    BioWorld
    Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
  • Purple molecules

    Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis

    BioWorld
    Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
  • Neck exam

    Ethyreal launches to treat the underlying cause of Graves’, TED

    BioWorld
    Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing